ClinicalTrials.gg
Drug

Odevixibat clinical trials

Also written A4250.

studies test it
10
open now
0
in phase 3
6
first study started
2013

How each study uses odevixibat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
20 Jul 2021 · BYLVAY · NDA 215498 (FDA, Drugs@FDA)
European Union
16 Jul 2021 · Bylvay · EMEA/H/C/004691 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Odevixibat
4
A4250 (odevixibat)
2

Development codes

A4250
7

Studies by the year they started

10 studies that test it; most in 2018 (3)

Studies that test odevixibat, by start year
YearStudies
20131
20152
20183
20201
20212
20221

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
2
Phase 3
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 1

Albireo (5) · Albireo, an Ipsen Company (4) · Sahlgrenska University Hospital (1)

Often tested with

Tested in the same studies.

Cholestyramine Resin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test odevixibat, phase 3 first.

Studies

Open first, then newest update. How each study uses odevixibat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Codes

What other systems call odevixibat · ClinicalTrials.gg INT001543

  • MeSH (NLM) C000713258odevixibatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2W150K0UUCODEVIXIBATConfirmed FDA, NLM, Wikidata
  • RxNorm 2563966One source FDA
  • Wikidata Q76415200odevixibatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166598OdevixibatOne source FDA
  • DrugBank DB16261One source Wikidata

Also registered as odevixibat sesquihydrate (UNII Q76KP2H4XW · RxNorm 2563978).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.